Departmental Seminar – March 4, 2016
Seminar Series: Spring 2016 ~~ Friday, March 4, 2016
2:00-3:00 PM
“The Role of Epigenetics in the Pathophysiology of Huntington’s Disease”
Ghazaleh Sadri-Vakili, PhD
Assistant Professor of Neurology, Harvard Medical School
Director, NeuroEpigenetics Laboratory;
Mass General Institute for Neurodegenerative Disease
Location & Time:
670 Albany Street
Lobby Level #107/108
2:00-3:00 PM
Friday, March 4, 2016
Target Audience: Faculty, Students, Residents, Greater Boston Scientific Community (advertised in MIT’s Bulletin).
At the conclusion of this activity participants will be able to: 1) repeat that transcriptional dysregulation has been proposed to play a major role in the pathology of Huntington’s disease; 2) recall that in Huntington’s disease specifically how alterations in transcription and epigenetic regulation can cause pathogenesis and 3) identify novel molecular/epigenetic mechanisms may unveil new therapeutic targets for the treatment of Huntington’s disease.
Course Director: Barbara Slack, PhD
Boston University School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. Boston University School of Medicine designates this educational activity for a maximum of 1 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.